Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM

Diabetes Care

Volumn 20, Issue 9, 1997, Pages 1408-1415

  Hanley, Anthony J G ^a,b   Harris, Stewart B ^c   Gao, X Joe ^a   Kwan, Jeremy ^b   Zinman, Bernard ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ABORIGINE; ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY FAT; CANADA; FEMALE; FITNESS; GLUCOSE TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SCHOOL CHILD;

EID: 0030848051     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.9.1408     Document Type: Article

References (46)

1. Barrett-Connor E: Epidemiology, obesity, and non-insulin-dependent diabetes mellitus. Epidemiol Rev 11:172-181, 1989
2. Jarrett RJ: Epidemiology and public health aspects of non-insulin-dependent diabetes mellitus. Epidemiol Rev 11:151-171, 1989.
3. Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968-977, 1983
4. Denke MA, Sempos CT, Grundy SM: Excess body weight: an underrecognized contributor to high cholesterol levels in white American men. Arch Intern Med 153:1093-1103, 1993
5. Bouchard C: Current understanding of the etiology of obesity: genetic and nongenetic factors. Am J Clin Nutr 53:1561S-1565S, 1991
6. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
7. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K: Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44:855-858, 1995
8. Rohner-Jeanrenaud F, Jeanrenaud B: Obesity, leptin and the brain. N Engl J Med 334:324-325, 1996
9. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
10. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: The ob gene and insulin: a relationship leading to clues to the understanding of obesity. Diabetes 44:1467-1470, 1995
11. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 337:527-529, 1995
12. MacDougald OA, Hwang C-S, Fan H, Lane MD: Regulated expression of the obese gene product (leptin) in white adipose tissues and 3T3-L1 adipocytes. Proc Natl Acad Sci USA 92:9034-9037, 1995
13. Zhang B, Graziano MP, Doebber TW, Liebowitz MD, White-Carrington S, Szalkowski DM, Hey PJ, Wu M, Cullinan CA, Bailey P, Lollmann B, Frederich R, Flier JS, Strader CD, Smith RG: Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 271:9455-9459, 199
14. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M: Analysis of human plasma leptin by radioimmunoassay. Clin Chem 42:942-946, 1996
15. Considine RV Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
16. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M: Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 45:695-698, 1996
17. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF: Acute and chronic effect of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 45:699-701, 1996
18. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in humans and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1:1155-1161, 1995
19. McGregor GP, Desaga JF, Ehlenz K, Fischer A, Hesse F, Hegele A, Lammer C, Peiser C, Lang RE: Radioimmunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 137:1501-1504, 1996
20. Hassink SG, Sheslow DV, de Lancey E, Opentanova I, Considine RV, Caro JF: Serum leptin in children with obesity: relationship to gender and development. Pediatrics 98:201-203, 1996
21. Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G: Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ 313:965-969, 1996
22. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL: Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 45:822-824, 1996
23. Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, El-Tawil K, Rude RK, Kamdar V: Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 82:579-584, 1997
24. Harris SB, Gittelsohn J, Hanley AJG, Barnie A, Wolever TMS, Gao J, Logan A, Zinman B: The prevalence of NIDDM and associated risk factors in aboriginal Canadians. Diabetes Care 20:185-187, 1997
25. Young TK: Health Care and Cultural Change: The Indian Experience in the Central Subarctic. Toronto, University of Toronto Press, 1988
26. Young TK: Are subarctic Indians undergoing the epidemiologic transition? Soc Sci Med 26:659-671, 1988
27. McIntyre L, Shah CP: Prevalence of hypertension, obesity and smoking in three Indian communities in northwestern Ontario. Can Med Assoc J 134:345-349, 1986
28. Delisle HF, Ekoe J: Prevalence of non-insulin-dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec. Can Med Assoc J 148:41-47, 1993
29. Fox C, Harris SB, Whalen-Brough E: Diabetes among native Canadians in northwestern Ontario: 10 years later. Chronic Dis Can 15:92-96, 1994
30. Hanley AJG, Harris SB, Barnie A, Gittelsohn J, Wolever TMS, Logan A, Zinman B: The Sandy Lake Health and Diabetes Project: design, methods and lessons learned. Chronic Dis Can 16:149-156, 1995
31. Gittelsohn J, Harris SB, Burris K, Kakegamic L, Landman L, Sharma A, Wolever TMS, Barnie A, Zinman B: Use of ethnographic methods for applied research on diabetes among Ojibway-Cree Indians in Northern Ontario. Health Educ Q 23:365-382, 1996
32. World Health Organization: Diabetes Mellirus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
33. Lipid Research Clinics Program: Manual of Laboratory Operations. Bethesda, MD, U.S. Govt. Printing Office, 1984, p. 1-81 (NIH publ. no. 756282)
34. Hanley AJG, Harris SB, Barnie A, Smith J, Logan A, Zinman B: Usefulness of bioelectrical impedance analysis in a population-based study of diabetes among Native Canadians (Abstract). Int J Obes 18 (Suppl. 2):O383, 1994
35. Sakamoto Y, Miura J, Yamaguchi Y, Ohno M, Ike Y: Usefulness of bioelectrical impedance analysis for measurement of body fat (Abstract). Int J Obes 18 (Suppl. 2):P501, 1994
36. Nunez C, Gallagher D, Russell-Aulet M, Heymsfield SB: Bioimpedance analysis of body fat composition: a new measurement approach (Abstract). Int J Obes 18 (Suppl. 2):P498, 1994
37. Tsui EYL, Gao XJ, Zinman B: Bioelectrical impedance analysis (BIA) in the assessment of body composition in non-insulin-dependent diabetes mellitus (Abstract [p. 260, no. 1119]). Proceedings of the 3rd International Diabetes Federation Western Pacific Regional Conference, 1996
38. Siconolfi SF, Garber LE, Lasater TM, Carleton RA: A simple step test for estimating maximal oxygen uptake in epidemiologic studies. Am J Epidemiol 121:382-390, 1985
39. SAS/STAT User's Guide, Version 6. 4th ed. Cary, NC, SAS Institute, 1990
40. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB: How useful is body mass index for comparison of body fatness across age, sex and ethnic groups? Am J Epidemiol 143:228-239, 1996
41. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G: UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab 82:654-657, 1997
42. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC: Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961-969, 1994
43. Han TS, Van Leer EM, Seidell JC, Lean MEJ: Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311:1401-1405, 1995
44. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D: Disproportionately elevated proinsulin in Pima Indians with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 70:1247-1253, 1990
45. Richter EA, Turcotte L, Hespel P, Kiens B: Metabolic responses to exercise: effects of endurance training and implications for diabetes. Diabetes Care 15:1767-1776, 1992
46. Bjorntorp P, Sjortrom L, Sullivan L: The role of physical exercise in the management of obesity. In Obesity. Skunkard AJ, Ed. Philadelphia, Saunders, 1980, p. 300-324